Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,32117,340 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Direct therapeutic intervention of the tumor microenvironment with a potent inhibitor of fibronectin assembly
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2024

PROJECT SUMMARY Among the hallmarks of cancer, the extracellular matrix contributes to the regulation of each of the hallmark principles underlying tumor progression. Importantly,...

$2.09M
USD
Completed NON-SBIR/STTR RPGS
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with high- risk acute myeloid leukemia (AML). However, HSCT is affect...

$3.6M
USD
Completed NON-SBIR/STTR RPGS
PAI-1-mediated early-onset endometrial cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

ABSTRACT PAI-1-mediated early-onset endometrial cancer Over the last 15-years, an increase in obesity-associated endometrial cancer has been observed, coinciding with the globesity...

$4.38M
USD
Completed TRAINING, INDIVIDUAL
Role of IRF2BP2 in Tumor Immune Evasion
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

PROJECT ABSTRACT Understanding the tumor microenvironment (TME) and the prognostic relevance of the cells contributing to it is vital for developing novel treatments for medullobla...

$517.5K
USD
Completed NON-SBIR/STTR RPGS
Treating colon cancer by regulating intestinal immunity through microbial metabolism
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2026

PROJECT SUMMARY Colorectal cancer (CRC) is profoundly affected by the intestinal immune system and the intestinal microbiome, which can exert both pro- and anti-cancer effects that...

$5.54M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the SWI/SNF complex in mediating hormone therapy resistance in breast cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

PROJECT SUMMARY Approximately 70% of breast cancers express estrogen receptor (ER) and are treated typically with endocrine therapy. Despite the clinical benefit obtained from seve...

$1.88M
USD
Completed NON-SBIR/STTR RPGS
Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2026

ABSTRACT Compared to non-Hispanic whites, African Americans have a more than 2-fold higher incidence of multiple myeloma (MM) and its asymptomatic precursor condition, monoclonal g...

$6.95M
USD
Completed NON-SBIR/STTR RPGS
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2026

ABSTRACTEffective responses to viruses, intracellular pathogens and tumors rely on the successful expansion and arming of cytolytic CD8 T cells from a naïve and quiescent T cell re...

$4.67M
USD
Completed NON-SBIR/STTR RPGS
Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance
NATIONAL CANCER INSTITUTE Suny Downstate Medical Center United States 2021 – 2026

PROGRAM SUMMARYRadiological imaging is often the first step of the diagnostic pathway for many devastating diseases; thus, an erroneous assessment of “normal” can lead to death. Wh...

$5.88M
USD
Completed NON-SBIR/STTR RPGS
Novel Strategies to Treat Diffuse Midline Glioma with CAR T Cell Therapy
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2023

PROJECT SUMMARY Although chimeric antigen receptor (CAR) T cells have been remarkably successful in the hematologic setting, identification of truly tumor specific antigens for man...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood. The consequence of this lack o...

$6.24M
USD
Completed OTHER RESEARCH-RELATED
Investigating the biology and therapeutic vulnerabilities of ER+ metastatic breast cancer with activating HER2 mutations
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

Project Summary/Abstract The candidate, Ms. Utthara Nayar, PhD, is a translational cancer biologist, and currently a Research Fellow in Medicine at Dana-Farber Cancer Institute, Ha...

$1.91M
USD
Completed NON-SBIR/STTR RPGS
Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Perinatal smoking negatively affects the baby and mother as well as healthcare costs; yet, up to one third of women who smoke continue to do so during pregnancy. We tested an SMS t...

$5.71M
USD
Completed NON-SBIR/STTR RPGS
The Effects of IQOS Use on Cigarette Smoking Behavior
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

PROJECT SUMMARY Despite increased morbidity and mortality, 34 million adults in the United States smoke combustible cigarettes. Heat-not-burn (HNB) tobacco products are an emerging...

$4.62M
USD
Completed NON-SBIR/STTR RPGS
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2022

ABSTRACT While overall colorectal cancer (CRC) incidence and mortality have declined over the last several decades, CRC incidence and mortality rates continue to be higher in Afric...

$10
USD
Completed NON-SBIR/STTR RPGS
Hyperthermic Intraperitoneal Chemotherapy Mechanisms in Epithelial Ovarian Cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2023

Project Summary Epithelial ovarian cancer (EOC) is a leading cause of gynecologic cancer death in women, highlighting the critical clinical need for new therapeutic strategies. In...

$1.84M
USD
Completed OTHER RESEARCH-RELATED
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary/Abstract Prostate cancer (PCa) is the second most incident cancer in men worldwide and despite vast amounts of research, treatment of this disease remains elusive....

$777.6K
USD
Completed NON-SBIR/STTR RPGS
Endometrial epithelial stem cells and cancer
NATIONAL CANCER INSTITUTE Cornell University United States 2021 – 2026

Uterine cancer is the 4th most frequent malignancy and the 6th cause of cancer-related deaths in women in the US. While the incidence and mortality rates of some cancers, such as l...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Control of regulatory T cells by IL-17 in colorectal cancer
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2021 – 2026

Project Summary/Abstract: IL-17 family cytokines promote inflammation that drives the development of colorectal neoplasia, which eventually lead to colorectal cancer (CRC). Thus fa...

$3.68M
USD
Completed SBIR-STTR RPGS
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
NATIONAL CANCER INSTITUTE Parabon Nanolabs, Inc United States 2021 – 2025

Project Summary This project addresses the critical need for treatments of castration resistant prostate cancer (CRPC) by proposing to engineer and develop a novel, nanostructured...

$1.49M
USD